In last trading session, Travere Therapeutics Inc (NASDAQ:TVTX) saw 1.09 million shares changing hands with its beta currently measuring 0.87. Company’s recent per share price level of $21.15 trading at $0.06 or 0.28% at ring of the bell on the day assigns it a market valuation of $1.88B. That closing price of TVTX’s stock is at a discount of -19.57% from its 52-week high price of $25.29 and is indicating a premium of 71.58% from its 52-week low price of $6.01.
For Travere Therapeutics Inc (TVTX), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.27. Splitting up the data highlights that, out of 8 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 8 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Travere Therapeutics Inc (NASDAQ:TVTX) trade information
Upright in the green during last session for gaining 0.28%, in the last five days TVTX remained trading in the green while hitting it’s week-highest on Monday, 05/12/25 when the stock touched $21.15 price level, adding 2.98% to its value on the day. Travere Therapeutics Inc’s shares saw a change of 21.41% in year-to-date performance and have moved 3.47% in past 5-day. Travere Therapeutics Inc (NASDAQ:TVTX) showed a performance of 41.85% in past 30-days.
Wall Street analysts have assigned a consensus price target of 21.5 to the stock, which implies a rise of 1.63% to its current value. Analysts have been projecting 12 as a low price target for the stock while placing it at a high target of 33. It follows that stock’s current price would jump 43.26% in reaching the projected high whereas dropping to the targeted low would mean a gain of 43.26% for stock’s current value.
Travere Therapeutics Inc (NASDAQ:TVTX)’s Major holders
BLACKROCK INC. is the top institutional holder at TVTX for having 7.64 million shares of worth $62.84 million. And as of 2024-06-30, it was holding 9.8642 of the company’s outstanding shares.
The second largest institutional holder is ARMISTICE CAPITAL, LLC, which was holding about 7.5 million shares on 2024-06-30. The number of shares represents firm’s hold over 9.6774 of outstanding shares, having a total worth of $61.65 million.
On the other hand, Delaware Group Equity Funds V-Macquarie Small Cap Core Fund and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Feb 28, 2025, the former fund manager was holding 3.45 shares of worth $73.01 million or 3.89% of the total outstanding shares. The later fund manager was in possession of 2.71 shares on Dec 31, 2024, making its stake of worth around $57.34 million in the company or a holder of 3.05% of company’s stock.
